Results 211 to 220 of about 45,912 (262)
Some of the next articles are maybe not open access.
Clinical Infectious Diseases, 1989
Several approaches to the development of a safe and effective vaccine against Vibrio cholerae are currently being pursued. These candidate vaccines include (1) live V. cholerae strains attenuated by recombinant DNA techniques; (2) killed whole V. cholerae organisms plus purified cholera enterotoxin B subunit; and (3) cloned V.
openaire +2 more sources
Several approaches to the development of a safe and effective vaccine against Vibrio cholerae are currently being pursued. These candidate vaccines include (1) live V. cholerae strains attenuated by recombinant DNA techniques; (2) killed whole V. cholerae organisms plus purified cholera enterotoxin B subunit; and (3) cloned V.
openaire +2 more sources
Vaccines for preventing cholera
2001Oral cholera vaccines (either killed whole cell or live recombinant vaccines) are newer alternatives to the parenteral vaccines which have been thought to confer only moderate and short-term immunity.The objective of this review was to assess the effect of cholera vaccines in preventing cases of cholera and preventing deaths.We searched the Cochrane ...
P, Graves +4 more
openaire +3 more sources
The Journal of tropical medicine and hygiene, 2008
Carol O. Tacket, David A. Sack
openaire +3 more sources
Carol O. Tacket, David A. Sack
openaire +3 more sources
Designing spatial and temporal control of vaccine responses
Nature Reviews Materials, 2021Shih Hao Ou, Wei Luo, Bali Pulendran
exaly
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
Nature Reviews Clinical Oncology, 2021Aakash Desai +2 more
exaly
SARS-CoV-2 variants, spike mutations and immune escape
Nature Reviews Microbiology, 2021William T Harvey +2 more
exaly